Sweden (4) (5) (6) . The wives and ex-wives of fishermen from the Swedish east and west coasts have reported that they consume more than twice as much fish than women from the general population (7, 8) . The fish from the western coast of Sweden are, however, much less contaminated with persistent organochlorine compounds (9) . This, taken together with a reasonable socioeconomic comparability of the groups, suggest that these women constitute proper study populations. In a previous cohort study we have shown that infants born to the wives of fishermen from the Swedish east coast during the period 1973-1991 had a higher frequency of low birth weight compared with infants bom to wives of fishermen from the Swedish west coast (7) . Furthermore, a first analysis of a nested case-control study, within the cohort of infants born to wives of fishermen from the Swedish east coast, indicated an increased risk of low birth weight among infants born to mothers who reported a relatively high current intake of fish from the Baltic Sea, as well as among infants born to mothers who had grown up in a fishing village (10) . Because the children studied were bom in the period 1973-1991, retrospective exposure assessments were of interest. No clear association was observed for the recalled estimated intake of fish for the time period during which the infant was born. The reliability of such long-term dietary recall is, however, not satisfactory (11) . This stresses the importance of supplementing interview data with exposure estimates based on persistent biomarkers of fish consumption.
Evidence for the use of 2,2',4,4',5,5'-hexachlorobiphenyl (CB-153, International Union of Pure and Applied Chemistry (IUPAC) number) as a marker for "dioxin-like" congeners of PCBs, and, under certain restrictions, also for total toxic equivalents (including PCDDs and PCDFs) in biotic samples, has been provided (1, 4) . In a study of 50 wives of fishermen from the Swedish east coast (a subset of the women in our present study), the correlation coefficient between CB-153 in plasma and the total PCB-toxic equivalent was 0.91 (12) . Moreover, in the same study, the plasma concentration of CB-153 and the sum of all 14 analyzed chlorinated biphenyls (CBs) in plasma was highly correlated (r = 0.99).
When the current CB-153 concentration is used to estimate past CB-153 concentration, it is important to account for certain factors.
Biihler et al. (13) estimated the half-life of CB-153 to be about 11 months when a single dose of a PCB mixture was orally ingested by a volunteer. However, the biologic half-life of CB-153 under prolonged exposure in humans is unknown. Based on experimental animal studies (14, 15) and analyses among long-term exposed participants in Operation Ranch Hand in Vietnam (16) , there is circumstantial evidence for a longer half-life for CB-153 in humans under prolonged exposure.
It is important to address the decreasing concentration of PCBs in fatty fish from the Baltic Sea over the last decades when interpreting the present CB-153 concentrations in plasma. According to data presented by Bignert et al. (17) , a yearly decrease between 3 and 5 percent seems a reasonable assumption.
Another aspect that has to be considered when assessing PCB exposure in women is that lactation probably substantially decreases the body burden. Only limited quantitative information is available; according to data from Skaare and Polder (18) a reduction of the body burden by a third for each lactation period seems to be a reasonable approximation. The most marked decline in PCB concentration was seen during the first weeks of lactation.
The aim of the present analysis in the nested casecontrol study was to assess the association between body burden of PCBs in women and the risk of low birth weights for their infants, using CB-153 in plasma as a relevant biomarker.
MATERIALS AND METHODS

Study base
A cohort of women who are, or were, married to fishermen from the Swedish east coast was established by linkage to the national Swedish population register and to registers at local parish offices (7) . These women were linked to the Swedish Medical Birth Register (19) . During the period 1973-1991, 757 women in the cohort had given birth to 1,501 infants.
Cases
In the cohort, 89 "case mothers" had, during the period 1973-1991, given birth to an infant who fulfilled the following criteria: singleton, birth weight within the interval 1,500-2,750 g, and without any major malformation (10) . If a mother had given birth to more than one infant with low birth weight, only the infant born first was eligible as a case. Of the 72 case mothers who were involved in our previous analysis (10) , 57 (79 percent) took part in the present study (table 1) .
Controls
The potential control mothers had given birth to an infant who fulfilled the following criteria: singleton, birth weight within the interval 3,250-4,500 g, and without any malformation (10) . Originally, two controls (referring to infants) were matched to each case according to gender, parity (1, 2, or ^3), and calendar year of birth (± 5 years). Among the 162 control mothers who were involved in the previous analysis, 135 (83 percent) took part in the present study (table  1) . Due to nonparticipant case mothers, controls were reallocated according to the matching criteria. This procedure resulted in five matched sets with one control, 32 sets with two controls, 14 sets with three controls, and six sets with four controls. For two of the included controls, however, it was impossible to fulfill the matching criteria; their and the corresponding cases' calendar years of birth differed by 7 and 8 years, respectively.
Blood sampling
From the 192 women studied, venous blood was drawn in 1995 from a cubital vein and collected in metal-free evacuated tubes (Venoject (Terumo Europe n.v., Leuven, Belgium)) with heparin as the anticoagulant. The plasma was stored at 4-8°C for a maximum of 72 hours before it was deep-frozen in ethanolwashed glass bottles and stored at -70°C until the analyses were performed. All samples were sent coded to the analytic laboratory. In Sweden, blood sera have been collected at antenatal clinics in a rubella-screening program. In certain geographic regions these samples have systematically been stored for years. For 20 (two case and 18 control) mothers in the present study it was possible to obtain deep-frozen blood sera from a pregnancy during the time period 1975-1991 (median 1987 ; for 11 of the 20 women, blood sera were obtained from a pregnancy not included in the present study). The median age of the women in the rubella screening was 28 (range 17-38) years.
Determination of CB-153
Analyses were performed using 0.5-3 g of plasma or serum. Internal standards, 2,3,3',5'-tetrachlorobiphenyl (CB-58) and 2,2',3,3',4,5,5',6-octachlorobiphenyl (CB-198), respectively, were added prior to clean-up.
The samples were extracted two times with 3 ml of hexane:methyl-tert-butyl ether, 1:1, and subsequently with 3 ml of hexane. Formic acid, 1.5 ml, was added at the first extraction as a denaturating agent.
The combined organic phase was concentrated and subsequently purified on two open columns, each packed with 1.5 g of silica gel 60 (Merck, Darmstadt, Germany) and eluted with 10 ml of hexane. The silica gel was cleaned by Sohxlet extraction in dichloromethane (Merck, distilled in house) and activated at 350°C, followed by deactivation with 10 percent of water (w/w) prior to use.
The final analysis was performed by gas chromatography-electron capture detection on a Varian 3400 instrument (Varian, Walnut Creek, California) using a Rtx-5 column (60 m X 0.25 mm, degrees of freedom = 0.25 fim) (Restek, Bellefonte, California). Hydrogen was used as carrier gas and nitrogen as make-up gas. The injector, operated in splitless mode, and the detector were set to 280°C and 310°C, respectively. The column was operated with a temperature program set at 60°C for 2 minutes, then raised by 7°C/min to 280°C, and held for 10 minutes. An ELDS Pro laboratory data system (Chromatography Data System, Svartsjo, Sweden) was used to register and process the signal from an electron capture detector.
Analyses of two separate homogenous fractions of 3 ml from nine collected samples demonstrated a coefficient of variation of less than 8 percent with a mean of 3.2 percent.
Determination of lipids by enzymatic methods
For the 192 blood samples collected in 1995, plasma concentrations of triglycerides, cholesterol, and phospholipids were determined by enzymatic methods using reagents from Boeringer-Mannheim (Mannheim, Germany) (triglycerides and cholesterol) and Waco Chemicals GmbH (Neuss, Germany) (phospholipids). The total lipid concentration in plasma was calculated by summation of the amounts of triglycerides, cholesterol, and phospholipids. In these calculations, the average molecular weights of triglycerides and phospholipids were assumed to be 807 and 714, respectively. For cholesterol, an average molecular weight of 571 was used, postulating that the proportion of free and esterified cholesterol in plasma was 1:2.
Additional data collection
When the blood samples were taken, information on the mothers' lactation history and smoking habits during the calendar year of childbirth were obtained by means of an interview (table 1) .
Statistics
Among the 20 mothers from whom sera at the rubella screening was obtained, the agreement between the fresh-weight concentration of CB-153 in plasma drawn in 1995, and at the rubella screening was calculated by the weighted kappa statistic (20) , using three categories (700, 701-1,200, and > 1,200 pg/g plasma). We also analyzed data, without applying any categorization, by statistics based on pairwise differences between individual CB-153 concentrations. Moreover, based on the concentration of CB-153 in 1995, we estimated the concentration level of CB-153 for each woman in the year of rubella screening from models that accounted for the impact of elimination rates during lactation and nonlactation periods, and the decrease of CB-153 concentration in fatty fish from the Baltic Sea over calendar time. accounts for "momentary" reductions of CB-153 due to lactations. Figure 1 illustrates the model for backcalculation of CB-153. The agreement between the estimated and measured CB-153 in the year of rubella screening was also assessed.
The odds ratio, adjusted for (in addition to the matching factors) maternal age and smoking habits during year of childbirth, was used for measuring the effect of exposure to CB-153 on low birth weight. The measured concentration of CB-153 in 1995, and the estimated concentration in the year of childbirth obtained under some alternative models (as described above), were considered as exposure variables. These were analyzed as continuous as well as categorized variables. The effect estimation was performed by means of conditional logistic regression (21) .
RESULTS
Agreement between estimated and measured CB-153 concentrations
The agreement between the CB-153 concentrations in the 1995 samples and in the rubella screening samples was fair (K = 0.30) (figure 2). The estimated concentrations at the year of rubella screening, based on several different model assumptions, gave higher K values with respect to measured concentrations in the rubella screening samples (table 2). 
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Rylander et al. ferent models applied, a fairly wide range of assumptions implied similar agreements (table 2) . However, a yearly reduction of CB-153 in fish of more than 5 percent led to worse agreement (data not shown). Moreover, biologic half-lives of CB-153 longer than 15 years, and higher than 50 percent reductions of body burden at each lactation period, did not improve the agreement.
In the following we focus on two alternative sets of assumptions: a 3 or 5 percent yearly reduction of CB-153 in fish, a 33 percent reduction of body burden of CB-153 at each period of lactation, and a 5-year half-life of CB-153 during nonlactating periods. We also briefly report on how robust the results are to variation in these model assumptions.
Measured CB-153 concentrations
The median concentration in 1995 of fresh-weight CB-153 in plasma was, for the whole study group {n = 192), 940 (range 80-4,300) pg/g. The case mothers had a higher median concentration than the control mothers (median concentrations were 1,000 (range 290-3,960) pg/g and 920 (range 80-4,300) pg/g). Also, for the lipid-adjusted concentrations of CB-153, a higher median concentration was seen among the case mothers (190 versus 160 ng/g lipid) (table 3). The lipid-adjusted concentrations were strongly correlated with the fresh-weight concentrations (r = 0.92).
Among the 20 women from whom blood samples at the time of rubella screening were available, the median fresh-weight concentration of CB-153 in serum 
Estimated concentrations of CB-153 in plasma during the year of childbirth
The estimated median concentration of lipidadjusted CB-153 in plasma during the year of childbirth was higher in the case mothers compared with the control mothers under the alternative models of interest (table 3) .
Naturally, the magnitude of the estimated concentrations of CB-153 during the year of childbirth became higher under models assuming a relatively low reduction of body burden at each period of lactation, a relatively high yearly reduction of CB-153 in the fish, or a relatively long biologic half-life of CB-153 during nonlactating time periods.
Lipid-adjusted concentration of CB-153 in plasma and low birth weight
After adjustment for maternal age and smoking habits during the year of childbirth, the concentration of plasma CB-153 in the 1995 samples, considered as a linear continuous variable, implied an odds ratio of 1.18 per 100 ng/g increase (95 percent confidence interval (CI) 0.86-1.63). When the exposure variable was dichotomized, a concentration of at least 200 ng/g lipid gave an odds ratio of 1.8 (95 percent CI 0.8-4.0) (table 4) . Thus, the data indicated a threshold effect rather than a linear relation between the log-odds and the CB-153 concentration.
Similarly, when the CB-153 concentration during year of childbirth was estimated under the models of interest, the continuous exposure variables did not imply a positively linear relation. We also categorized the exposure variables. The cutpoints of the estimated CB-153 concentration that indicated an increased risk were 300 or 400 ng/g lipid (odds ratios of 2.1 (95 percent CI 1.0-4.7) or 2.3 (95 percent CI 0.9-5.9)) (table 4). Indeed, the exposure dichotomizations of the cases and controls based on measured and estimated CB-153 concentrations, respectively, were fairly similar, although the relevant cutpoints differed.
Other assumptions of the biologic half-life of CB-153 during nonlactating periods, implied similar risks of a low birth weight at CB-153 concentrations around 300-400 ng/g lipid (odds ratios between 1.8 and 2.3, with lower 95 percent confidence limits between 0.8 and 1.0). Moreover, other assumptions of yearly reduction of CB-153 concentration in fish and reduction of maternal body burden of CB-153 at each period of lactation implied fairly similar effect estimates.
Additional product terms between estimated CB-153 concentration (provided from the models focused on), on the one hand, and parity, gender of the infafiC calendar year of childbirth, maternal age, or smoking during the year of childbirth, respectively, on the other, did not significantly improve the fits of the logistic models (p > 0.10, likelihood ratio test). Hence, there was no clear evidence of effect modification.
When the datasets were analyzed using an unmatched design, the results were not noticeably affected.
DISCUSSION
The main finding of the present study was that a relatively high prenatal exposure to CB-153 was associated with an increased risk for low birth weight. Incorporation of a dichotomous exposure variable into the logistic model generally revealed an increased risk, in contrast to continuous (not transformed) exposure variables. Thus, the results may suggest a threshold effect, both when the measured CB-153 concentrations in plasma in the 1995 samples and when the estimated concentrations during the year of childbirth were considered as the exposure variable. The results indicated an increased risk of a low birth weight at 300-400 ng/g lipid with respect to estimated concentrations of CB-153 in plasma during the year of childbirth, obtained under some biologically plausible assumptions.
In the previous case-control study, the response rate was somewhat lower for case mothers than for control mothers (10); the fractions of mothers who also participated in the present investigation (i.e., who donated blood samples) were similar among the case and control mothers (about 80 percent), respectively. The educational levels were lower among both nonparticipating case and control mothers (table 1) . On the other hand, based on data from the previous analysis (10), the fractions of nonsmokers among participating and nonparticipating mothers were almost the same (data not shown). In addition, the age distributions were similar among participants and nonparticipants.
We have, in a previous analysis of this case-control study using "estimated fish consumption" as well as "grown up in a fishing village" as the exposure measure, observed no distinct differences in the odds ratio estimates for low birth weight as compared with small for gestational age (10) . The lack of precision in the Swedish Medical Birth Register for gestational length made such a discrimination difficult (19) . It should be noticed, on the other hand, that the register quality of birth weight, which is used in the analysis, is good. Thus, misclassification of the employed outcome variable was not a problem.
In our previous cohort study, low birth weight was considered to be <2,500 g, as well as <3,000 g (7). We chose 1,500-2,750 g as the case definition in our following case-control study, which gave a sufficient number of cases. The birth weight interval of the controls was set to 3,250-4,500 g, rather than 2,750-4,500 g, in order to avoid adjacent outcome categories and, presumably, design a more efficient study (by assuming that the true odds ratio was thereby increased).
The precision of the concentrations of CB-153 in plasma in the 1995 samples was good. We also estimated the concentrations of CB-153 in plasma during the year of childbirth from models that accounted for the impact of influential factors. Due to the limited knowledge about the magnitude of such factors, there may have been a negative impact on precision, as well as accuracy, of estimated CB-153 concentrations. For validation of the estimated concentrations obtained from these models, the agreement between estimated and measured CB-153 concentrations in the year of rubella screening was assessed, based on a subset (n = 20) of study participants. This validation, however, had some shortcomings. 1) The concentrations of CB-153 in the samples obtained in the year of rubella screening were all determined from small amounts of sera, which might have decreased the precision of the laboratory analysis. 2) Even though lipid adjustment improves the comparability, it was only feasible to perform the comparisons between concentrations of fresh-weight CB-153. The fresh-weight and lipidadjusted concentrations of CB-153 in the 1995 plasma samples, however, were highly correlated (r = 0.90; n = 20).
3) The obtained sera samples from the rubella screenings were mainly from the latter part of the study period, which made validation of the estimated concentrations during the earlier part of the study period impossible. 4) We disregarded data on individual fish consumptions when developing the kinetic models because these data were not sufficiently reliable (11) and, therefore, the exposure assessments based on CB-153 concentrations were aimed to be independent of reported fish consumption. An assumption on constant fish consumption over calendar time underlies the kinetic models considered. Such a restriction may be important in contributing to the lack of agreement. Despite these shortcomings, a better agreement was obtained for the comparison between estimates based on the kinetic models and the measured concentrations in the year of rubella screening, than for the comparison between the measured concentrations in the 1995 samples and in the rubella screening samples, respectively.
The estimated concentrations of CB-153 in plasma during the year of childbirth were most likely affected by nondifferential errors. Assuming that the probability of low birth weight was almost constant within each exposure category, nondifferential exposure misclassification should have occurred (22) . Such misclassification tends to produce an underestimation of the actual relative risk (23) . Even if the probability of low birth weight increased with increasing CB-153 concentration, an underestimation of the true effect would be expected (22) .
As mentioned in the introduction to this paper, the biologic half-life of CB-153 is long; we assumed 5 years in the kinetic models we focused on. This means that seasonal variation in fish diet (if such exists) will only marginally affect the body burden of CB-153 in the mothers.
It is usually essential to develop kinetic models in order to perform retrospective exposure assessments. In the present context, such models were based on biologically plausible assumptions, although we stress that current knowledge is limited. Nevertheless, the kinetic models presented provide a framework for retrospective estimation of prenatal exposure to PCBs, and can be used in further studies.
In the present analyses we adjusted for (in addition to the matching factors of gender, parity, and calendar year of birth) maternal age and smoking habits during year of childbirth, two well-known risk factors for low birth weight (24) . Different classifications of these variables did not noticeably affect the results. A number of additional possible confounders (e.g., alcohol consumption) have been evaluated in univariate logistic regression analyses, but were not found to have any impact on birth weight (10) .
A negative association between PCB exposure through maternal consumption of fish and birth weight has been reported among the wives of sport fishermen in the Lake Michigan area in the United States (25) . Our results support this finding. Such an association may have serious implications if it occurs in parallel with an impairment of the neurologic development of infants. Jacobson et al. (26, 27) showed, based on a follow-up until 4 years of age in the Lake Michigan study, that prenatal PCB exposure was associated not only with lower weight, but also with poorer shortterm memory on both verbal and quantitative tests. A recent publication indicated that prenatal exposure to PCBs can have an even more long-term impact on intellectual functions (28); at 11 years of age, the most highly prenatally PCB-exposed children were about three times as likely to have a low average intelligence quotient score and about twice as likely to be at least 2 years behind in reading comprehension. In the Lake Michigan studies, the mean concentration of total PCBs in maternal serum samples was 5.5 ng/ml (standard deviation = 3.7) (25) . The concentrations of total PCBs were not assessed in the present study. However, for 50 of the mothers in the present study, concentrations of 14 specific PCB congeners in plasma were assessed (12) . The range of the sum of these CBs (1.0-10.7 ng/g) was very similar as compared with those for the Lake Michigan mothers. Due to differences in the analytic methods, the comparison, however, should be interpreted with some caution.
The median concentration of CB-153 in plasma among the wives of fishermen from the Swedish east coast was similar to the mean of the blood plasma concentration of CB-153 in samples collected from a group of women in the Netherlands during their last month of pregnancy (29) . In the Netherlands study, subtle signs of neurologic dysfunctioning and a small delay in psychomotor development, together with a lower birth weight, were associated with prenatal exposure to persistent organochlorine compounds (30, 31) . On the other hand, in a study on the general population in North Carolina, prenatal persistent organochlorine compound exposure was not associated with birth weight but with subtle neurologic developmental effects in infants up to 2 years of age (32, 33) .
Our study is retrospective in design, and, therefore, does not allow a direct assessment of subtle neurologic developmental outcomes. Such an evaluation requires a prospective study with neuropsychologic tests at certain points in time. The observation made in most of the previous studies that prenatal persistent organochlorine compound exposure implied both subtle neurologic developmental deficits and low birth weight, is, however, noteworthy.
